期刊文献+

激素对慢性阻塞性肺疾病患者IL-8和LTB_4及肺功能的影响 被引量:8

The IL-8,LTB_4 levels and the pulmonary function of patients with chronic obstructive pulmonary disease around hormone treatment
下载PDF
导出
摘要 目的:观察在治疗慢性阻塞性肺疾病急性加重期(AECOPD)时全身应用糖皮质激素对痰上清液和血清中白介素8(IL-8)和白三烯B4(LTB4)及肺功能的影响。方法:将33例AECOPD患者随机分为治疗组17例,对照组16例。两组均给予常规治疗,同时治疗组给予静脉和口服甲泼尼龙或泼尼松,观察比较两组治疗前后痰上清液和血清中IL-8和LTB4水平、肺功能及呼吸困难(VAS)改善情况。结果:治疗前,痰上清液和血清中IL-8、LTB4水平均高于治疗后,二者间有直线相关关系;且与第1秒钟用力呼气容积(FEV1)、第1秒钟用力呼气容积占预计值百分比(FEV1%)、第1秒钟用力呼气容积与用力肺活量的比值(FEV1/FVC)间有负相关(P<0.05)。治疗后,痰上清液IL-8、LTB4的变化与痰中性粒细胞百分比(Neu%)、VAS的变化有显著相关性(P<0.05)。与对照组相比,治疗组呼吸困难症状缓解快,痰中性粒细胞减少、痰上清液和血清中IL-8、LTB4的下降水平、FEV1、FEV1%和FEV1/FVC改善幅度均较大。结论:AECOPD患者IL-8和LTB4水平增高,这些变化与临床症状和肺功能相关。使用激素可减轻炎症反应、改善肺功能和缓解患者临床症状。 Aim:To observe the levels of IL-8,LTB4 in the sputum and serum and the pulmonary function in patients with acute exacerbations of chronic obstructive pulmonary disease around systemic glucocorticoid treatmen. Methods: A total of 33 cases of AECOPD were randomly divided into two groups,the treatment group(17 cases),and the controlled(16 cases).The two groups took the conventional treatment.At the same time,the treatment group received additionlly the intravenous and oral methylprednisolone or predisone.The changes of the levels of IL-8,LTB4 in the sputum and serum,the pulmonary function and VAS were observed after the treatment,which were compared.Results: Before hormone the treatment,the levels of IL-8,LTB4 in serum and sputum were significantly higher than after treatment,which had a significantly linear correlation and had inverse correlations with the FEV1,FEV1% and FEV1/FVC(P〈0.05).There was a significant correlation with the changes of IL-8、LTB4 in sputum and the changes of Neu%.Compared with the controlled,the treatment improved dyspnea.Moreover,the levels of IL-8、LTB4 in serum and sputum,Neu% decreased significally,while the FEV1% and FEV1/FVC showe an remakable improvement.Conclusion:In those AECOPD patients,the levels of IL-8,LTB4 showed the significant alterations.All these changes have the correlation with the pulmonary function and the presences of clinical symptoms.It is suggested that the early corticosteroid treatment can relieve the inflammation of airway,improve the pulmonary function and alleviate the discomfort of the patients.
出处 《暨南大学学报(自然科学与医学版)》 CAS CSCD 北大核心 2010年第2期186-189,202,共5页 Journal of Jinan University(Natural Science & Medicine Edition)
基金 广东省社会发展领域科技计划项目(粤科社字[2003]245号)
关键词 慢性阻塞性肺疾病 白介素8 白三烯B4 chronic obstruction pulmonary dsiease(COPD) interleukin 8(IL-8) leukotrienes B4(LTB4)
  • 相关文献

参考文献11

  • 1ZHONG N S, WANG C, LIU S M, et al. Prevalence of Chronic Obstructive Pulmonary Disease in China: A Large, Population-based Survey [ J]. Am J Respir Crit Care Med, 2007, 176(8) : 753 -760.
  • 2NHBLI/WHO workshop report. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease [ EB/OL]. [ 2007 ] http://www. goldcopd, com/GuidelineItem, asp? intId = 1955.
  • 3TANINO M, BET S T, TAKEYABU K, et al. Increased levels of interleukin-8 in BAL fluid from smokers susceptible to pulmonary emphysema [ J ]. Thorax, 2002, 57 (5) : 405 -411.
  • 4BEEH K M, KORNMANN O, BUHL R, et al. Neutrophil chemotaetie activity of sputum from patients with COPD: role of interleukin 8 and leukotriene B4 [ J ]. Chest, 2003, 123 (4) :1240 -1247.
  • 5慢性阻塞性肺疾病诊治指南(2007年修订版)[J].中华结核和呼吸杂志,2007,30(1):8-17. 被引量:8232
  • 6HACIEVLIYAGIL S S, GUNEN H, MUTLU L C, et al. Association between cytokines in induced sputum and severity of chronic obstructive pulmonary disease. Respir Med, 2006,100 ( 5 ) : 846 - 854.
  • 7PUNEET P, MOOCHHALA S, BHATIA M. Chemokines in acute respiratory distress syndrome [ J ]. Am J Physiol Lung Cell Mol Physiol, 2005,288( 1 ) : 3 -15.
  • 8MCCAIN R W, HOLDEN E P, BLACKWELL T R, et al. Leukotriene B4 stimulates human polymorphnuclear leukocytes to synthesize and release intefleukin-8 in vitro [J]. Am J Respir Cell Mol Biol, 1994, 10(6) :651 - 657.
  • 9CROOKS S W, BAYLEY D L, HILL S L, et al. Bronchial inflammation in acute bacterial exacerbations of chronic bronchitis : the role of leukotriene B4 [ J ]. Ear Respir J, 2000,15 (2) :274 - 280.
  • 10丁艳苓,姚婉贞,刘政,王玉柱.慢性阻塞性肺疾病患者诱导痰和血浆中白三烯B_4的变化以及茶碱对其的影响[J].中华结核和呼吸杂志,2005,28(7):441-444. 被引量:13

二级参考文献17

  • 1有创-无创序贯机械通气多中心研究协作组.以肺部感染控制窗为切换点行有创与无创序贯机械通气治疗慢性阻塞性肺疾病所致严重呼吸衰竭的随机对照研究[J].中华结核和呼吸杂志,2006,29(1):14-18. 被引量:279
  • 2Crooks SW,Stockley RA. Leukotriene B4. Int J Biochem Cell Biol,1998,30:173-178.
  • 3Kilfeather S. 5-lipoxygenase inhibitors for the treatment of COPD. Chest,2002,121(5 Suppl):197S-200S.
  • 4Stafanger G,Garne S,Howitz P,et al. The clinical effect and the effect on the ciliary motility of oral N-acetylcysteine in patients with cystic fibrosis and primary ciliary dyskinesia. Eur Respir J,1988,1:161-167.
  • 5Rutgers SR,Timens W,Kaufmann HF,et al. Comparison of induced sputum with bronchial wash,bronchoalveolar lavage and bronchial biopsies in COPD. Eur Respir J,2000,15:109-115.
  • 6Silkoff PE,Martin D,Pak J,et al. Exhaled nitric oxide correlated with induced sputum findings in COPD. Chest,2001,119:1049-1055.
  • 7Juergens UR,Stober M,Vetter H. Reproterol--A monomolecular combination of orciprenaline and theophylline:novel aspects of its mode of action in asthma. Respiration,1999,66:220-224.
  • 8Peleman RA,Kips JC,Pauwels RA. Therapeutic activities of theophylline in chronic obstructive pulmonary disease. Clin Exp Allergy,1998,28 Suppl 3:53-56.
  • 9GOLD Executive Committee[DB/OL].Guidelines:Global Strategy for Diagnosis,Management,and Prevention of COPD,November 2006[2006-11-18].http://www.goldcopd.com/Guidelineitem.asp? l1 =2-12 = 1&intId =989.
  • 10Celli BR,MacNee W,Committee members.Standard for the diagnosis and treatment of patients with COPD:a summary of the ATS/ERS position paper.Eur Respir J,2004,23:932-946.

共引文献8241

同被引文献66

引证文献8

二级引证文献43

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部